The main health threat in developing states today is not plagues or parasites but illnesses such as cancer and diabetes, noncommunicable diseases long associated with the rich world.

Thomas J. Bollyky discusses President Obama's nomination of Jim Yong Kim to lead the World Bank.

In an era of global supply chains, the United States should pursue regulatory integration on a regional basis. A new White House initiative provides the opportunity to implement this strategy.

Thomas Bollyky writes about how national patent laws are affecting pharmaceutical cost differentials around the world.

Thomas Bollyky assesses President Obama's record in promoting international science in the latest issue of Science. The president has made strides in integrating science into U.S. diplomacy and international development activities, but only modest progress on facilitating the day-to-day scientific exchanges that account for most international research.

As tobacco use proliferates in the developing world, an innovative incentive mechanism could supplement tobacco control efforts in low- and middle-income countries.

The winner of the 2012 presidential election faces an important leadership test on trade, which will have challenges and opportunities, says CFR's Thomas Bollyky, including leveling the playing field with China and finalizing the Trans-Pacific Partnership.

As tobacco reemerges as a contentious issue in trade policy, CFR Senior Fellow Thomas Bollyky argues that the Obama administration can better balance U.S. mandates on tobacco trade policy with its interests in promoting global health and U.S. standing abroad.